7 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 29948358 | Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study. | 2018 Oct | 5 |
2 | 30384012 | Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysis. | 2018 Dec | 1 |
3 | 29188773 | Sorafenib tosylate, Ribavirn and Sofosbuvir combination therapy for HCV virus infected patients with decompensated liver cancer. | 2017 Nov | 1 |
4 | 25789012 | Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis. | 2015 Apr | 2 |
5 | 26029452 | Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction. | 2015 Jun | 1 |
6 | 21445543 | Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function. | 2011 Nov | 1 |
7 | 21883324 | Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. | 2011 Oct | 3 |